CRAD B Share Price | C-RAD AB Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare C-RAD AB with Similar Stocks

SyntheticMR AB Devyser Diagnostics AB Doxa AB

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a fall in Net Sales of -12.92%, the company declared Very Negative results in Dec 25

PRE-TAX PROFIT(Q) At SEK -0.7 MM has Fallen at -102.78%
NET PROFIT(Q) At SEK 1.6 MM has Fallen at -88.97%
ROCE(HY) Lowest at 3.09%

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 861 Million (Micro Cap)

P/E

43.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.49

Return on Equity

3.00%

Price to Book

2.48

Revenue and Profits:

Net Sales:

106 Million

(Quarterly Results - Dec 2025)

Net Profit:

2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-15.94%

6 Months

-15.53%

1 Year

-40.88%

2 Years

-10.15%

3 Years

-42.06%

4 Years

-53.31%

5 Years

-13.29%

C-RAD AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.81%

EBIT Growth (5y)

26.25%

EBIT to Interest (avg)

29.86

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.49

Sales to Capital Employed (avg)

1.46

Tax Ratio

39.10%

Dividend Payout Ratio

32.15%

Pledged Shares

Institutional Holding

ROCE (avg)

32.53%

ROE (avg)

10.39%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.22

EV to EBIT

13.38

EV to EBITDA

11.95

EV to Capital Employed

5.13

EV to Sales

2.11

PEG Ratio

Dividend Yield

ROCE (Latest)

38.32%

ROE (Latest)

7.56%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -12.92% vs -12.21% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -88.97% vs -45.28% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105.80",
          "val2": "121.50",
          "chgp": "-12.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.00",
          "val2": "24.40",
          "chgp": "-59.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.60",
          "val2": "14.50",
          "chgp": "-88.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "68.10%",
          "val2": "174.50%",
          "chgp": "-10.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -5.78% vs 10.46% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -81.38% vs 58.87% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "441.90",
          "val2": "469.00",
          "chgp": "-5.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "70.30",
          "val2": "74.10",
          "chgp": "-5.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29.20",
          "val2": "0.30",
          "chgp": "9,633.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.50",
          "val2": "56.40",
          "chgp": "-81.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "135.80%",
          "val2": "149.80%",
          "chgp": "-1.40%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

105.80

121.50

-12.92%

Operating Profit (PBDIT) excl Other Income

10.00

24.40

-59.02%

Interest

6.10

0.00

Exceptional Items

0.00

Consolidate Net Profit

1.60

14.50

-88.97%

Operating Profit Margin (Excl OI)

68.10%

174.50%

-10.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -12.92% vs -12.21% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -88.97% vs -45.28% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

441.90

469.00

-5.78%

Operating Profit (PBDIT) excl Other Income

70.30

74.10

-5.13%

Interest

29.20

0.30

9,633.33%

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

10.50

56.40

-81.38%

Operating Profit Margin (Excl OI)

135.80%

149.80%

-1.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -5.78% vs 10.46% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -81.38% vs 58.87% in Dec 2024

All Annual Results

Company CV

About C-RAD AB

C-RAD AB

Pharmaceuticals & Biotechnology

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Company Coordinates

Company Details

Bredgrand 18 , UPPSALA None : 753 20

Tel: 46 18 666930

https://c-rad.se/

Registrar Details